Stevanato Group S.p.A. (STVN) shares are soaring 5.55% in pre-market trading on Thursday following the release of its impressive first-quarter 2025 financial results. The Italian medical packaging company reported earnings that surpassed analyst expectations, demonstrating robust growth and resilience in a challenging market environment.

For the quarter ended March 31, Stevanato reported adjusted earnings of €0.10 per share, beating the FactSet consensus estimate of €0.09. This represents a significant improvement from €0.08 per share in the same quarter last year. Revenue for Q1 reached €256.6 million, comfortably exceeding analysts' expectations of €247.3 million and marking an 8.7% increase year-over-year. The company's net income stood at €26.5 million, outperforming the IBES estimate of €24.8 million.

Adding to the positive sentiment, Stevanato provided a strong outlook for the full year 2025. The company projects revenue between €1,160 million and €1,190 million, with adjusted EBITDA ranging from €288.5 million to €301.8 million. While Stevanato slightly trimmed its full-year adjusted EPS guidance to €0.50-€0.54 from the previous €0.51-€0.55, it remains in line with market expectations. The company also noted its ongoing efforts to mitigate potential impacts, including the ramp-up of its Fishers, Indiana facility, which is expected to help offset any future challenges.